Bethesda Hospital

4052 (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£1,190,155

Aug 23 - Aug 25

Preclinical efficacy and safety studies of ADAM33 oligonucleotides as new disease-modifying asthma therapy

MRC award to University of Southampton and Hans Haitchi

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}